Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
LRRK2 is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain.
our similar early study and recent confirming experiments using the same reagents reported by Sheng et al. failed to reproduce the phenotype of the loss of dopaminergic neurons, although the mRNA of LRRK2 was molecularly disrupted
results demonstrate that zLRRK2 is an ortholog of hLRRK2 and that the deletion of WD40 domain (show DCAF12L2 ELISA Kits) of zLRRK2 provides a disease model for PD
LRRK2 p.Gly2385Arg can explain most if not all of the PD association at rs1994090 in East Asians, but other nonsynonymous variants are independent.
This study showed that LRRK2, PARK2 (show PARK2 ELISA Kits) and ATP13A2 (show ATP13A2 ELISA Kits) are under copy number variations influence in patient with Parkinson disease.
decreased levels of miRNAs targeting LRRK2 might result in a gain of function for LRRK2, and by extension, loss of neuronal viability
Pathogenic LRRK2 variants mapping to different functional domains increase phosphorylation of Rab (show HRB ELISA Kits) GTPases and this strongly decreases their affinity to regulatory proteins.
Knockdown of either ULK1 (show ULK1 ELISA Kits) or DLP1 (show DNM1L ELISA Kits) expression with shRNAs suppresses LRRK2 G2019S expression-induced mitochondrial clearance, suggesting that LRRK2 G2019S expression induces mitochondrial fission through DLP1 (show DNM1L ELISA Kits) followed by mitophagy via an ULK1 (show ULK1 ELISA Kits) dependent pathway.
Parkinson disease is likely a pathogenically heterogeneous condition and it suggests the existence of specific mechanisms involved in LRRK2-associated PD.
Asymptomatic carriers of the R1441G-leucine-rich repeat kinase 2 mutation have evidence of dopaminergic nigrostriatal denervation
Our findings demonstrate that SP1 (show PSG1 ELISA Kits) attenuates mutant LRRK2-induced PD-like phenotypes and plays a neural protective role.
This study demostrated that G2019S LRRK2 mutation parkinson disease and REM (show REM1 ELISA Kits) sleep behavior disorder.
This is the first study indicating that Sp1 (show PSG1 ELISA Kits) signaling plays an important role in the regulation of human LRRK2 gene expression.
In the present study demonstrated that the up-regulation of HOTAIR and LRRK2 in the midbrain of PD mice induced by MPTP (show PTPN2 ELISA Kits).
that mutant LRRK2 may impair synaptic vesicle dynamics via aberrant phosphorylation of N-ethylmaleimide sensitive fusion
14-3-3theta can regulate LRRK2 and reduce the toxicity of mutant LRRK2 through a reduction of kinase activity.
LRRK2 has a role in microglia activation and sustainment of neuroinflammation.
p21-activated kinase 6 (PAK6 (show PAK6 ELISA Kits)) as a novel interactor of leucine-rich repeat kinase 2 (LRRK2), a kinase involved in Parkinson's disease
The data implicate gain of LRRK2 function in the pathogenesis of Parkinson disease
LRRK2 regulates lysosome size, number and function in primary astrocytes and results show that expression of Parkinson's disease associated LRRK2 variants results in enlarged lysosomes
Present results suggest that LRRK2 may play novel roles in both the immune system and the pathogenesis of various diseases.
Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression
In the substantia nigra of LRRK2 transgenic mice, mRNA of three genes that promote cell death was upregulated, while the mRNA expression of seven genes that contribute to neurogenesis/neuroprotection was downregulated.
show that the LRRK2 sequence and expression patterns are conserved between pig and human
This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8.
leucine-rich repeat serine/threonine-protein kinase 2
, leucine-rich repeat kinase 2
, leucine-rich repeat serine/threonine-protein kinase 2-like
, augmented in rheumatoid arthritis 17